Fulminant progression of demyelinating disease after valproate-induced encephalopathy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9674826.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the clinical, radiologic, and pathologic features of a patient who had fulminant demyelinating disease and who experienced acute progression of his disease after an episode of valproate-induced hyperammonemic encephalopathy. The role hyperammonemia played in the progression of the demyelination is uncertain. This case raises concern of a possible risk with the use of valproic acid in the subset of patients with fulminant demyelinating disease.
Medical subject headings
- Anticonvulsants
- Demyelinating Diseases
- Encephalitis
- Valproic Acid